01
Biomedical Innovation
Readiness assessment, evidence-gap clarification and strategic positioning of biomedical and translational innovation with potential for responsible institutional implementation.
Preparing biomedical innovation for responsible healthcare implementation across borders.
A women-led health innovation venture connecting biomedical readiness, institutional context and implementation pathways across healthcare systems.
Who we are
A readiness-to-implementation venture for cross-border healthcare innovation.
SHEFA prepares selected biomedical, MedTech and healthtech innovations for responsible institutional evaluation and implementation pathways through readiness assessment, institutional translation and structured execution.
Built through European expertise and deep understanding of the UAE healthcare context, SHEFA creates structured pathways between innovation, evidence, institutional evaluation and responsible implementation.
Strategic areas
02
Healthcare Diplomacy
Translating healthcare priorities, institutional context and cultural considerations between European innovators and UAE healthcare ecosystems, with progressive GCC expansion as the next step.
03
International Strategic Alliances
Structuring potential collaboration pathways across research, healthcare and innovation ecosystems where evidence, institutional fit and mutual value justify progression.
04
UAE Market Readiness & Institutional Pathways
Preparing selected innovations for qualified institutional engagement in the UAE through market readiness, stakeholder mapping and structured implementation pathways.
05
Implementation Readiness & Innovation Activation
Preparing the transition from biomedical innovation towards responsible implementation through validation planning, pilot architecture, governance and structured activation pathways.
Current Biomedical Opportunity Domains
SHEFA’s early readiness work spans selected biomedical opportunities across surgical MedTech, advanced surgical preparation, specialised clinical pathways and emerging translational science. SHEFA does not own the underlying technologies; its role is to structure the readiness and implementation pathway around them.
01
Surgical MedTech & Perioperative Intelligence
Readiness and implementation questions around surgical safety, procedural coordination, traceability and institutional integration.
02
Advanced Surgical Preparation
Readiness pathways involving anatomical modelling, simulation, procedural preparation, validation planning and institutional adoption requirements.
03
Emerging Biomedical & Translational Science
Responsible exploration of emerging biomedical opportunities where scientific fit, evidence maturity and governance must be assessed before implementation is considered.
Why SHEFA
A focused combination of biomedical readiness, institutional context and cross-border execution.
Institutional Context & Engagement
Understanding healthcare priorities, stakeholder environments and the conditions required for qualified institutional engagement.
Strategic Intelligence
Translating scientific, institutional and market complexity into structured readiness decisions and implementation pathways.
Cross-Cultural Understanding
Operational understanding of UAE healthcare and institutional environments, with progressive GCC expansion as the next step.
Execution
Beyond advice — structured next steps from readiness assessment to responsible activation where evidence justifies progression.
Founders
Rania El Ghauche
Healthcare diplomacy, institutional relations, UAE healthcare context and international development.
Ana Garrido
Strategy, project structuring, governance, funding architecture and execution across complex scientific and institutional environments.
International outlook
Built in Barcelona.
Designed for international healthcare ecosystems.
UAE first. GCC next.
SHEFA’s current geographic focus is the UAE, where its readiness-to-implementation model is being applied and refined. Progressive GCC expansion is the next geographic step.
Selective by design
SHEFA operates through a highly selective collaboration model, prioritising strategic alignment, institutional value and long-term impact.
We engage in opportunities where biomedical credibility, institutional relevance and execution can create meaningful long-term value.
01
Healthcare ecosystems require more than innovation alone.
02
Institutional context and trust shape responsible cross-border healthcare collaboration.
03
Readiness, alignment and execution shape responsible international healthcare collaboration.
Strategic Conversations &
International Collaboration
Barcelona, Spain